<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0001382'>Joint hypermobility</z:hpo> syndrome (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">JHS</z:e>) was initially defined as the occurrence of musculoskeletal symptoms in the presence of <z:hpo ids='HP_0001388'>joint laxity</z:hpo> and hypermobility in otherwise healthy individuals </plain></SENT>
<SENT sid="1" pm="."><plain>It is now perceived as a commonly overlooked, underdiagnosed, multifaceted, and multisystemic <z:e sem="disease" ids="C0019247" disease_type="Disease or Syndrome" abbrv="">heritable disorder</z:e> of connective tissue (HDCT), which shares many of the phenotypic features of other HDCTs such as <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> and <z:e sem="disease" ids="C0013720" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Ehlers-Danlos syndrome</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Whereas the additional flexibility can confer benefits in terms of mobility and agility, adverse effects of tissue laxity and fragility can give rise to clinical consequences that resonate far beyond the confines of the musculoskeletal system </plain></SENT>
<SENT sid="3" pm="."><plain>There is hardly a clinical specialty to be found that is not touched in one way or another by <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">JHS</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Over the past decade, it has become evident that of <z:hpo ids='HP_0000001'>all</z:hpo> the complications that may arise in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">JHS</z:e>, <z:hpo ids='HP_0011010'>chronic</z:hpo> pain is arguably the most menacing and difficult to treat </plain></SENT>
</text></document>